Article info
Review
Sphingosine 1-phosphate, a potential target in neovascular retinal disease
- Correspondence to Dr Christian Waeber, School of Pharmacy, University College Cork, Cork, Ireland; c.waeber{at}ucc.ie
Citation
Sphingosine 1-phosphate, a potential target in neovascular retinal disease
Publication history
- Received February 17, 2021
- Revised April 17, 2021
- Accepted April 23, 2021
- First published May 7, 2021.
Online issue publication
August 19, 2022
Article Versions
- Previous version (7 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.